Carbone Cancer Center, Madison, WI
Noelle K. LoConte, Allison Antoine, A. Michelle Corbett, Carrie Stehman, David Frazer, Abhishek Ticku, Aronica Williams, Elissa Sprecher, Allison Kos
Background: Colorectal cancer continues to be very common, and a widening racial disparity has been demonstrated. Wisconsin’s Comprehensive Cancer Control Program which is a program of the University of Wisconsin Carbone Cancer Center partnered with nine Federally Qualified Health Centers (FQHCs) on this five-year program to increase colorectal cancer (CRC) screening. Methods: This project was funded by the CDC and was a partner of a state’s comprehensive cancer control program and a variety of community health centers. Activities included clinical and environmental assessment and baseline data review of CRC screening, identification of a CRC screening team at each clinic, selection and implementation and evaluation of a panel of evidence-based interventions (EBI) per the The Community Guide to Preventive Services. Ongoing implementation data tracking and monitoring strategies were used to create opportunities for data-informed decisions at each clinic. Results: FIT kits were the preferred CRC screening modality. The preferred EBI were patient reminder systems, provider reminders, reducing structural barriers, professional education, EMR improvements and small media. Screening rates for CRC increased by 17% over the course of the project with a peak weighted average of screening at 51.8% for eligible average risk adults, which was up from a baseline of 34.8%. Over 9,000 take-home stool kits were distributed, and a 60.7% completion rate was achieved. The positivity rate for the FIT kits across all centers was 7.6%. A subset of the patients with a positive FIT (n = 97) were reviewed and 53.7% (n = 51) did not have a documented colonoscopy in their electronic medical record. Conclusions: This project of an academic-community partnership was successful in increasing CRC screening in medically underserved communities in Wisconsin. The positivity rate in this high needs population was higher than expected based on prior publications. Further efforts should focus on decreasing the gap between positive FIT testing and completion colonoscopy.
Health System | A | B | C | D | E | F | G | H | I |
---|---|---|---|---|---|---|---|---|---|
# of patients 50-75 | 1087 | 5242 | 1824 | 5633 | 2070 | 911 | 529 | 2012 | 782 |
# of PCPs | 19 | 26 | 9 | 101 | 15 | 9 | 7 | 21 | 4 |
Racial/ethnic population served | 40% Hispanic 38% NHW 23% Black 2% Asian 1% AI/AN | 4% Hispanic 5% NHW 91% Black | 7% Hispanic 21% NHW 72% Black | 88% Hispanic 6% NHW 5% Black 2% Asian | 3% Hispanic 7% NHW 86% Black 5% Asian | 88% Hispanic 4% NHW 3% Black 4% Asian | 32% Hispanic 18% NHW 16% Black 49% AI/AN | 30% Hispanic 43% NHW 24% Black 7% Asian 4% AI/AN | 15% Hispanic 81% NHW 2% Black 1% Asian |
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2024 ASCO Gastrointestinal Cancers Symposium
First Author: Brendan Chia
2024 ASCO Annual Meeting
First Author: Yoanna S. Pumpalova
2024 ASCO Gastrointestinal Cancers Symposium
First Author: Derek W. Ebner
2023 ASCO Annual Meeting
First Author: Derek W. Ebner